
Vivos Therapeutics VVOS
$ 0.73
2.89%
Annual report 2025
added 04-15-2026
Vivos Therapeutics EV/EBITDA Ratio 2011-2026 | VVOS
Annual EV/EBITDA Ratio Vivos Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.43 | -12.3 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.43 | -12.3 | -7.39 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
730 | $ 3.51 | 1.74 % | $ 131 M | ||
|
Helius Medical Technologies
HSDT
|
-0.0925 | $ 2.19 | 1.62 % | $ 1.33 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 17.3 | 1.5 % | $ 406 M | ||
|
LivaNova PLC
LIVN
|
215 | $ 66.41 | 15.32 % | $ 3.62 B | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
Myomo
MYO
|
-2.96 | $ 0.83 | -5.03 % | $ 34.7 M | ||
|
Orthofix Medical
OFIX
|
31.1 | $ 12.23 | -1.69 % | $ 484 M | ||
|
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
-8.6 | $ 7.17 | -29.96 % | $ 1.08 B | ||
|
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | ||
|
Insulet Corporation
PODD
|
95.3 | $ 155.04 | -7.46 % | $ 10.9 B | ||
|
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | ||
|
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | ||
|
Sintx Technologies
SINT
|
0.974 | $ 2.56 | 5.79 % | $ 7.1 M | ||
|
Stryker Corporation
SYK
|
30 | $ 295.04 | -0.07 % | $ 113 B | ||
|
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
-9.73 | $ 11.19 | 0.77 % | $ 317 M | ||
|
TransMedics Group
TMDX
|
-12.1 | $ 73.91 | -22.14 % | $ 2.51 B | ||
|
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | ||
|
Tandem Diabetes Care
TNDM
|
215 | $ 18.45 | -5.02 % | $ 1.25 B | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.61 | 1.6 % | $ 38 M | ||
|
Delcath Systems
DCTH
|
-1.69 | $ 11.51 | -0.17 % | $ 412 M | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Varex Imaging Corporation
VREX
|
18.2 | $ 11.72 | 1.65 % | $ 485 M | ||
|
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.05 | -0.48 % | $ 17.8 M | ||
|
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
26.4 | $ 26.2 | 1.51 % | $ 221 M | ||
|
Butterfly Network
BFLY
|
-3.9 | $ 4.7 | -2.59 % | $ 995 M | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
27.6 | $ 90.08 | 0.06 % | $ 12.2 B | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 36.43 | -0.57 % | $ 1.13 B | ||
|
Inspire Medical Systems
INSP
|
-152 | $ 46.56 | -3.5 % | $ 1.37 B | ||
|
Integer Holdings Corporation
ITGR
|
18.2 | $ 87.68 | 2.13 % | $ 3.05 B | ||
|
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
39.2 | $ 83.05 | 0.17 % | $ 48.6 B | ||
|
Tactile Systems Technology
TCMD
|
241 | $ 24.38 | 1.37 % | $ 558 M |